EU approves Roche drug Columvi for lymphoma treatment
Roche: EU approves Columvi for lymphoma treatment
Keystone-SDA
Select your language
Generated with artificial intelligence.
Listening: EU approves Roche drug Columvi for lymphoma treatment
The European Commission has approved Roche's Columvi as the first bispecific antibody for the treatment of diffuse large B-cell lymphoma after initial therapy, the pharmaceutical giant announced on Monday.
This content was published on
2 minutes
Keystone-SDA
Italiano
it
Roche: Ue approva Columvi per trattamento linfoma
Original
The approval is based on the result of the phase III Starglo trial, during which Columvi – combined with Gemcitabine and oxaliplatin (GemOx) – demonstrated a “statistically and clinically significant improvement in survival” compared to other treatments, Roche explained.
Relapsed or refractory diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer with a high risk of progression, which means that urgent and effective treatments are needed. In primary analyses, a 41% reduction in the risk of death was found among patients treated with Columvi and GemOx.
Translated from Italian by DeepL/ts
How we work
We select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate them into English. An editor then briefly reviews the translation for clarity and accuracy before publication. Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.
In Switzerland more people are being referred to electrical therapies or psychedelic-assisted psychotherapy. Are there similar approaches where you live?
Renewal of war in Gaza has ‘unleashed a new hell’, says Red Cross
This content was published on
The resumption of the war in Gaza has unleashed a new hell in the Palestinian territory, the director of the Geneva-based ICRC has warned.
Lufthansa set to abolish in-flight sales, SWISS to keep them
This content was published on
Perfumes, cigarettes, sunglasses: The German airline Lufthansa will no longer sell these products on long-haul flights in future. Lufthansa subsidiary Swiss is sticking to in-flight sales for the time being.
This content was published on
After a short break due to the cool weather, grass pollen is now flying in Switzerland, the Swiss Allergy Centre said on Monday.
This content was published on
Researchers have shown for the first time in Switzerland that urban greenery measurably reduces the stress levels of city dwellers.
US tariffs affect canton Zurich less than other locations
This content was published on
The Zurich cantonal government is observing the developments surrounding the US tariffs "with concern". Compared to other locations, however, Zurich should get off lightly.
This content was published on
The Alpine Museum in Bern is showing the finds of diver David Godio, who has been fishing lost objects out of the River Aare for years.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.